{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:01:00Z","timestamp":1781658060382,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Consejo Nacional de Investigaciones Cient\u00edficas y Tecnol\u00f3gicas","award":["PIP 2011-0471"],"award-info":[{"award-number":["PIP 2011-0471"]}]},{"name":"Secretar\u00eda de Ciencia y Tecnolog\u00eda de la UNR","award":["BIO300"],"award-info":[{"award-number":["BIO300"]}]},{"name":"Secretar\u00eda de Ciencia y Tecnolog\u00eda de la UNR","award":["BIO498"],"award-info":[{"award-number":["BIO498"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jpba.2019.03.021","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T12:54:44Z","timestamp":1552568084000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Chemometric study of the excipients\u2019 influence on polymorphic-behavior. Mefenamic acid as case of study"],"prefix":"10.1016","volume":"170","author":[{"given":"Marina","family":"Antonio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1099-3686","authenticated-orcid":false,"given":"Natalia L.","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n M.","family":"Maggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2019.03.021_bib0005","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jps.2600580802","article-title":"Pharmaceutical applications of polymorphism","volume":"58","author":"Haleblian","year":"1969","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2019.03.021_bib0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.addr.2003.10.008","article-title":"Drug polymorphism and dosage form design: a practical perspective","volume":"56","author":"Singhal","year":"2004","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.jpba.2019.03.021_bib0015","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1021\/jp500988k","article-title":"Mefenamic acid anti-inflammatory drug: probing its polymorphs by vibrational (IR and Raman) and solid-state NMR spectroscopies","volume":"118","author":"Cunha","year":"2014","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.jpba.2019.03.021_bib0020","series-title":"Polymorphism in Pharmaceutical Solids","author":"Brittain","year":"2009"},{"key":"10.1016\/j.jpba.2019.03.021_bib0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpba.2017.07.048","article-title":"Quantification of gabapentin polymorphs in gabapentin\/excipient mixtures using solid state 13C NMR spectroscopy and X-ray powder diffraction","volume":"146","author":"Tinmanee","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.03.021_bib0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.addr.2003.10.009","article-title":"Phase transformation considerations during process development and manufacture of solid oral dosage forms","volume":"56","author":"Zhang","year":"2004","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.jpba.2019.03.021_bib0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jpba.2011.05.017","article-title":"Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms","volume":"56","author":"Tita","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.03.021_bib0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpba.2013.06.016","article-title":"Drug\u2013excipient compatibility screening\u2014Role of thermoanalytical and spectroscopic techniques","volume":"87","author":"Chadha","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.03.021_bib0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpba.2014.12.031","article-title":"The effect of excipients on the stability and phase transition rate of xylazine hydrochloride and zopiclone","volume":"107","author":"Kr\u016bkle-B\u0113rzi\u0146a","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.03.021_bib0050","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jpba.2004.01.012","article-title":"Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations","volume":"35","author":"Verma","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.03.021_bib0055","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/jps.20679","article-title":"Investigation of a process induced instability due to formation of amorphous ABT-232 in tablets","volume":"95","author":"Wardrop","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2019.03.021_bib0060","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jpba.2017.06.018","article-title":"Chemometrics-assisted solid-state characterization of pharmaceutically relevant materials. Polymorphic substances","volume":"147","author":"Calvo","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.03.021_bib0065","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jpba.2009.09.017","article-title":"Rietveld refinement in the routine quantitative analysis of famotidine polymorphs","volume":"51","author":"N\u00e9met","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.03.021_bib0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0731-7085(98)00171-X","article-title":"Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy","volume":"18","author":"Mura","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.03.021_bib0075","series-title":"Developing Solid Oral Dosage Forms","first-page":"59","author":"Law","year":"2017"},{"key":"10.1016\/j.jpba.2019.03.021_bib0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jpba.2016.07.013","article-title":"Determination of the main solid-state form of albendazole in bulk drug, employing Raman spectroscopy coupled to multivariate analysis","volume":"129","author":"Calvo","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.03.021_bib0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpba.2016.01.035","article-title":"Mebendazole crystal forms in tablet formulations. An ATR-FTIR\/chemometrics approach to polymorph assignment","volume":"122","author":"Calvo","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.03.021_bib0090","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jpba.2015.01.016","article-title":"A PCA-based chemometrics-assisted ATR-FTIR approach for the classification of polymorphs of cimetidine: application to physical mixtures and tablets","volume":"107","author":"Calvo","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.03.021_bib0095","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jpba.2017.11.053","article-title":"Assessment of mefenamic acid polymorphs in commercial tablets using chemometric coupled to MIR and NIR spectroscopies. Prediction of dissolution performance","volume":"149","author":"Antonio","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.03.021_bib0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jpba.2013.12.036","article-title":"A dynamic thermal ATR-FTIR\/chemometric approach to the analysis of polymorphic interconversions. Cimetidine as a model drug","volume":"92","author":"Calvo","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.03.021_bib0105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jpba.2018.06.019","article-title":"Chemometrics-assisted study of the interconversion between the crystalline forms of nimodipine","volume":"158","author":"Calvo","year":"2018","journal-title":"J. Pharm. Biomed.Anal."},{"key":"10.1016\/j.jpba.2019.03.021_bib0110","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0002-9378(92)91614-G","article-title":"Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia","volume":"166","author":"Van Eijkeren","year":"1992","journal-title":"Am. J. Obstetrics Gynecol."},{"key":"10.1016\/j.jpba.2019.03.021_bib0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vibspec.2004.06.001","article-title":"Infrared studies of the thermal conversion of mefenamic acid between polymorphic states","volume":"37","author":"Gilpin","year":"2005","journal-title":"Vibr. Spectr."},{"key":"10.1016\/j.jpba.2019.03.021_bib0120","first-page":"17","article-title":"Thermodynamische Beziehungen zwischen polymorphen","author":"Burger","year":"1980","journal-title":"Modifikationen: Flufenaminsiure und Mefenaminsiure, Mikrochim. Acta"},{"key":"10.1016\/j.jpba.2019.03.021_bib0125","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1248\/cpb.33.2073","article-title":"A kinetic study on the isothermal transition of polymorphic forms of tolbutamide and mefenamic acid in the solid state at high temperatures","volume":"33","author":"Umeda","year":"1985","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jpba.2019.03.021_bib0130","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.saa.2012.07.129","article-title":"Raman and IR spectroscopic studies of fenamates. Conformational differences in polymorphs of flufenamic acid, mefenamic acid and tolfenamic acid spectrochim","volume":"96","author":"Jabeen","year":"2012","journal-title":"Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.jpba.2019.03.021_bib0135","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1002\/jps.22194","article-title":"Quantitative evaluation of mefenamic acid polymorphs by terahertz\u2013chemometrics","volume":"99","author":"Otsuka","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2019.03.021_bib0140","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/jps.20008","article-title":"Solid-state characterization of mefenamic acid","volume":"93","author":"Panchagnula","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2019.03.021_bib0145","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1039\/C6AY02799G","article-title":"Rapid identification and quantification of carbohydrate excipients in Gardeniae Fructus formula granules by ATR-FTIR spectroscopy","volume":"47","author":"Chen","year":"2016","journal-title":"Anal. Methods"},{"key":"10.1016\/j.jpba.2019.03.021_bib0150","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.talanta.2013.09.037","article-title":"Blending process modeling and control by multivariate curve resolution","volume":"15","author":"Jaumot","year":"2013","journal-title":"Talanta"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518328243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518328243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:54:23Z","timestamp":1760000063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708518328243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":30,"alternative-id":["S0731708518328243"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2019.03.021","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemometric study of the excipients\u2019 influence on polymorphic-behavior. Mefenamic acid as case of study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2019.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}